NCT03735199

Brief Summary

Following tooth extraction, the socket heals naturally with bone in 1 to 2 months. This healing process occurs with substantial reduction of the original height and width of the alveolar ridge. In a significantly resorbed ridge, bone augmentation procedures are necessary before dental implant placement. Autogenous bone is the gold standard for this purpose but the harvesting procedure results in additional morbidities and expenses. Ridge preservation techniques have been introduced, using xenografts, allografts or synthetic materials to fill the tooth socket immediately after extraction. While the current materials used have improved ridge dimensions to various extents, their osteoconductivity is suboptimal and unpredictable. They do not reduce vertical resorption of the bony walls and often interfered with the normal healing process. Polycaprolactone - tricalcium phosphate (PCL-TCP) is a bioactive, bioresorbable composite polymer that is non-toxic and tissue-compatible. This study will test the use of a novel 3D printed PCL-TCP device for ridge preservation, leveraging on its 3D shape that fits snugly in the tooth socket, high porosity and bioactivity to promote osteogenesis and reduce resorption. The hypothesis is that the insertion of a PCL-TCP scaffold in extraction sockets allows normal bone healing and better maintenance of ridge dimensions after 6 months compared to extraction sockets without a space filler. This will be a prospective, randomized controlled clinical trial in patients who require single tooth extraction and replacement with a dental implant. The study will compare the ridge dimensions and the quality and quantity of bone formed in tooth sockets, using histology and microcomputed tomography, in both groups after 6 months. The PCL-TCP scaffold to be used in this study will be fabricated by a local spin-off company, Osteopore International Pte Ltd. The market potential for this device is tremendous due to a growing demand for tooth replacement from an ageing population worldwide.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 8, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

February 28, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2023

Completed
Last Updated

November 13, 2023

Status Verified

November 1, 2023

Enrollment Period

4.5 years

First QC Date

October 3, 2018

Last Update Submit

November 8, 2023

Conditions

Keywords

3D Printed Scaffold Device

Outcome Measures

Primary Outcomes (1)

  • Alveolar ridge resorption

    This will be measured indirectly as the vertical distance from each reference marking on the stent to the marginal bone of the tooth socket at the mesio-buccal, mid-buccal and disto-buccal aspects

    6 months post-extraction

Secondary Outcomes (4)

  • Quality of bone tissue formed in tooth sockets

    6 months post-extraction

  • Quantity of bone tissue formed in tooth sockets

    6 months post-extraction

  • Stability of dental implant

    6 months post-extraction

  • Healing and inflammatory response in tooth sockets

    6 months post-extraction

Study Arms (2)

PCL-TCP scaffold

EXPERIMENTAL

During the surgery, the PCL-TCP scaffold will be shaped by cutting and shaving with a scalpel so as to fit the extraction socket snugly at the crestal half to two-thirds aspect. A Geistlich Bio-Gide collagen membrane will be placed over the scaffold at the crestal aspect of the socket. The periosteum of the buccal flap will then be incised to allow a tension-free primary closure with 4/0 Vicryl® suture.

Device: PCL-TCP scaffoldDevice: Geistlich Bio-Gide collagen membrane

Geistlich Bio-Gide collagen membrane

ACTIVE COMPARATOR

No space filler will be inserted in the extraction socket but similar to the test group, a Geistlich Bio-Gide collagen membrane will be placed over the crestal aspect of the socket and the periosteum of the buccal flap will be incised to allow a tension-free primary closure with 4/0 Vicryl® suture. denture overlying the extraction site will be completely relieved.

Device: Geistlich Bio-Gide collagen membrane

Interventions

During the surgery, the scaffold will be shaped by cutting and shaving with a scalpel so as to fit the extraction socket snugly at the crestal half to two-thirds aspect. A collagen membrane will be placed over the scaffold at the crestal aspect of the socket. The periosteum of the buccal flap will then be incised to allow a tension-free primary closure with 4/0 Vicryl® suture.

PCL-TCP scaffold

A collagen membrane will be placed over the crestal aspect of the socket and the periosteum of the buccal flap will be incised to allow a tension-free primary closure with 4/0 Vicryl® suture.

Geistlich Bio-Gide collagen membranePCL-TCP scaffold

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient must be above 21 and below 70 years of age (both inclusive)
  • Patient must be of ASA I or ASA II classification
  • Patient who requires single tooth extraction
  • Patient whose tooth to be extracted is bounded by adjacent teeth
  • Patient who is suitable for dental implant therapy after extraction

You may not qualify if:

  • Patient with known allergy to biopolymer materials
  • Patient who are smokers
  • Patient who has undergone therapeutic radiation for head and neck malignant disease
  • Maxillary lateral incisor and molars; or mandibular central and lateral incisor extraction sites
  • Extraction sites with insufficient vertical bone height for implant placement without additional bone grafting (such as sinus lift procedure)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Dental Centre Singapore

Singapore, 168938, Singapore

Location

Study Officials

  • Bee Tin Goh

    National Dental Centre, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant, Department of Oral & Maxillofaical Surgery, Clinical Associate Professor, Director of Research, NDCS

Study Record Dates

First Submitted

October 3, 2018

First Posted

November 8, 2018

Study Start

February 28, 2019

Primary Completion

September 6, 2023

Study Completion

September 6, 2023

Last Updated

November 13, 2023

Record last verified: 2023-11

Locations